The impact of chronic kidney disease on cognitive function

被引:2
|
作者
Pepin, Marion [1 ,2 ,3 ]
Levassort, Helene [1 ,2 ,3 ]
Massy, Ziad A. [2 ,3 ,4 ,5 ]
机构
[1] Ambroise Pare Univ Hosp, Geriatr Dept, APHP, Boulogne Billancourt, France
[2] Paris Sud Univ UPS, Hop Paul Brousse, Clin Epidemiol Team, Inserm,U 1018,CESP, Villejuif, France
[3] Versailles St Quentin Yvelines Univ UVSQ, Villejuif, France
[4] Assoc Utilisat Rein Artificiel Reg Parisienne AURA, Paris, France
[5] Ambroise Pare Univ Hosp, Nephrol Dept, APHP, Boulogne Billancourt, France
来源
关键词
biomarkers; chronic kidney disease; cognitive impairment; interdisciplinary; risk factors; INDOXYL SULFATE; DEMENTIA; DECLINE;
D O I
10.1097/MNH.0000000000001017
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewThe risk of cognitive impairment is higher in people with CKD than in the general population. The complex relationship between CKD and cognitive dysfunction has not been extensively characterized. Here, we review epidemiological associations, specific patterns of CKD-related cognitive impairment, the underlying mechanisms, and recently published data on relevant biomarkers.Recent findingsDespite some discrepancies, recent published studies have confirmed that CKD is associated with cognitive function (e.g. incident cognitive events). Although patients with CKD often exhibit impairments in executive functions and attention, it is noteworthy that other cognitive functions (e.g. memory) can be preserved. The key mechanisms described recently include vascular damage, genetic factors, the accumulation of uremic toxins, disruption of the blood-brain barrier, glymphatic system dysfunction, and changes in the gut-brain axis. Kidney function is increasingly seen as a game changer in the interpretation of biomarkers of cognitive impairment and, especially, hallmarks of Alzheimer disease.SummaryThe data reviewed here highlight the need for interdisciplinary collaboration between nephrologists and neurologists in the care of patients with CKD at risk of cognitive impairment. In order to further improving diagnosis and therapy, future research must elucidate the mechanisms underlying the CKD-cognitive impairment association and confirm the value of biomarkers.
引用
收藏
页码:566 / 572
页数:7
相关论文
共 50 条
  • [41] Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease
    Giannakou, Konstantinos
    Golenia, Aleksandra
    Liabeuf, Sophie
    Malyszko, Jolanta
    Mattace-Raso, Francesco
    Farinha, Ana
    Spasovski, Goce
    Hafez, Gaye
    Wiecek, Andrzej
    Capolongo, Giovanna
    Capasso, Giovambattista
    Massy, Ziad A.
    Pepin, Marion
    FRONTIERS IN MEDICINE, 2023, 10
  • [42] The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review
    Hannan, Mary
    Steffen, Alana
    Quinn, Lauretta
    Collins, Eileen G.
    Phillips, Shane A.
    Bronas, Ulf G.
    JOURNAL OF NEPHROLOGY, 2019, 32 (02) : 211 - 230
  • [43] Mild chronic kidney disease is associated with cognitive function in patients presenting at a memory clinic
    Romijn, Marloes D. M.
    van Marum, Rob J.
    Emmelot-Vonk, Marielle H.
    Verhaar, Harald J. J.
    Koek, Huiberdina L.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 30 (07) : 758 - 765
  • [44] Association of brain white matter lesions and atrophy with cognitive function in chronic kidney disease
    Yeh, Yi-Chun
    Kuo, Yu-Ting
    Huang, Mei-Feng
    Hwang, Shang-Jyh
    Tsai, Jer-Chia
    Kuo, Mei-Chuan
    Chen, Cheng-Sheng
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 34 (12) : 1826 - 1832
  • [45] Association between chronic kidney disease and the cognitive function in subjects without overt dementia
    Ito, Hiroyuki
    Antoku, Shinichi
    Mori, Toshiko
    Nakagawa, Yoshitaka
    Mizoguchi, Katsumi
    Matsumoto, Suzuko
    Omoto, Takashi
    Shinozaki, Masahiro
    Nishio, Shinya
    Abe, Mariko
    Mifune, Mizuo
    Togane, Michiko
    CLINICAL NEPHROLOGY, 2018, 89 (05) : 330 - 335
  • [46] The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review
    Mary Hannan
    Alana Steffen
    Lauretta Quinn
    Eileen G. Collins
    Shane A. Phillips
    Ulf G. Bronas
    Journal of Nephrology, 2019, 32 : 211 - 230
  • [47] Impact of Iodinated Contrast on Renal Function and Hemodynamics in Rats with Chronic Hyperglycemia and Chronic Kidney Disease
    Fernandes, Sheila Marques
    Martins, Daniel Malisani
    da Fonseca, Cassiane Dezoti
    Watanabe, Mirian
    Fernandes Vattimo, Andmaria de Fatima
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [48] HOMOCYSTEINE AND COGNITIVE IMPAIRMENT IN CHRONIC KIDNEY DISEASE
    Yeh, Y. -C.
    Kuo, M. -C.
    Hwang, S. -J.
    Hsioa, S. -M.
    Tsai, J. -C.
    Huang, M. -F.
    Chen, C. -S.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [49] Cognitive Dysfunction in Patients with Chronic Kidney Disease
    Aggarwal, H. K.
    Jain, Deepak
    Bhavikatti, Aswvini
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2020, 31 (04) : 796 - 804
  • [50] Chronic kidney disease, creatinine and cognitive functioning
    Elias, Merrill F.
    Elias, Penelope K.
    Seliger, Stephen L.
    Narsipur, Sriram S.
    Dore, Gregrory A.
    Robbins, Michael A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (08) : 2446 - 2452